Your browser doesn't support javascript.
loading
Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".
Brunschwig, Christel; Lawrence, Nina; Taylor, Dale; Abay, Efrem; Njoroge, Mathew; Basarab, Gregory S; Le Manach, Claire; Paquet, Tanya; Gonzàlez Cabrera, Diego; Nchinda, Aloysius T; de Kock, Carmen; Wiesner, Lubbe; Denti, Paolo; Waterson, David; Blasco, Benjamin; Leroy, Didier; Witty, Michael J; Donini, Cristina; Duffy, James; Wittlin, Sergio; White, Karen L; Charman, Susan A; Jiménez-Díaz, Maria Belén; Angulo-Barturen, Iñigo; Herreros, Esperanza; Gamo, Francisco Javier; Rochford, Rosemary; Mancama, Dalu; Coetzer, Theresa L; van der Watt, Mariëtte E; Reader, Janette; Birkholtz, Lyn-Marie; Marsh, Kennan C; Solapure, Suresh M; Burke, John E; McPhail, Jacob A; Vanaerschot, Manu; Fidock, David A; Fish, Paul V; Siegl, Peter; Smith, Dennis A; Wirjanata, Grennady; Noviyanti, Rintis; Price, Ric N; Marfurt, Jutta; Silue, Kigbafori D; Street, Leslie J; Chibale, Kelly.
Afiliação
  • Brunschwig C; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Lawrence N; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Taylor D; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Abay E; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Njoroge M; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Basarab GS; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Le Manach C; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch, South Africa.
  • Paquet T; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch, South Africa.
  • Gonzàlez Cabrera D; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch, South Africa.
  • Nchinda AT; Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch, South Africa.
  • de Kock C; Drug Discovery and Development Centre (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, South Africa.
  • Waterson D; Medicines for Malaria Venture, Geneva, Switzerland.
  • Blasco B; Medicines for Malaria Venture, Geneva, Switzerland.
  • Leroy D; Medicines for Malaria Venture, Geneva, Switzerland.
  • Witty MJ; Medicines for Malaria Venture, Geneva, Switzerland.
  • Donini C; Medicines for Malaria Venture, Geneva, Switzerland.
  • Duffy J; Medicines for Malaria Venture, Geneva, Switzerland.
  • Wittlin S; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • White KL; University of Basel, Basel, Switzerland.
  • Charman SA; Centre for Drug Candidate Optimisation, Monash University, Melbourne, Victoria, Australia.
  • Jiménez-Díaz MB; Centre for Drug Candidate Optimisation, Monash University, Melbourne, Victoria, Australia.
  • Angulo-Barturen I; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Madrid, Spain.
  • Herreros E; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Madrid, Spain.
  • Gamo FJ; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Madrid, Spain.
  • Rochford R; GlaxoSmithKline, Tres Cantos Medicines Development Campus, Madrid, Spain.
  • Mancama D; Department of Immunology and Microbiology, University of Colorado, Aurora, Colorado, USA.
  • Coetzer TL; Biosciences, Council for Scientific and Industrial Research, Pretoria, South Africa.
  • van der Watt ME; Plasmodium Molecular Research Unit, Wits Research Institute for Malaria, Department of Molecular Medicine and Haematology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
  • Reader J; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Pretoria, South Africa.
  • Birkholtz LM; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Pretoria, South Africa.
  • Marsh KC; Department of Biochemistry, Institute for Sustainable Malaria Control and South African Medical Research Council Collaborating Centre for Malaria Research, University of Pretoria, Pretoria, South Africa.
  • Solapure SM; AbbVie, North Chicago, Illinois, USA.
  • Burke JE; Nagarjuna Gardens, Bangalore, India.
  • McPhail JA; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Vanaerschot M; Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
  • Fidock DA; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, USA.
  • Fish PV; Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York, USA.
  • Siegl P; Division of Infectious Diseases, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
  • Smith DA; Alzheimer's Research UK UCL Drug Discovery Institute, Faculty of Brain Sciences, University College London, London, United Kingdom.
  • Wirjanata G; Siegl Pharma Consulting LLC, Blue Bell, Pennsylvania, USA.
  • Noviyanti R; Independent Researcher, Walmer, Kent, United Kingdom.
  • Price RN; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • Marfurt J; Eijkman Institute for Molecular Biology, Jakarta, Indonesia.
  • Silue KD; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
  • Street LJ; Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Chibale K; Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia.
Antimicrob Agents Chemother ; 62(11)2018 11.
Article em En | MEDLINE | ID: mdl-30355750
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article